NYCRX INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2007

Legal Domicile

Principal Officer

PETER GRISAFI

Phone

6464983986

Tax Period

2018-07-01 to 2019-06-30

NYCRX INC, founded in 2007, is a small nonprofit that reported $227K in total revenue in fiscal year 2018. Revenue fell 83% from the prior year — a significant decline worth monitoring. Expenses of $717K exceeded revenue, resulting in a 216% operating deficit.

Mission

TO PROVIDE ACCESS TO LOW-COST PRESCRIPTIONS TO THE MEDICALLY UNDERSERVED, AND TO SUPPORT ELIGIBLE SAFETY NET PROVIDERS IN MAXIMIZING THE USE OF THE 340B DRUG DISCOUNT PROGRAM.

Program Service Accomplishments

Program 1

Expenses: $465,919 Revenue: $226,632

340B MANAGEMENT IS THE BY FAR THE MAIN PROGRAMMATIC SERVICE AREA FOR NYCRX. WE MANAGE THE 340B PROGRAMS FOR FEDERALLY QUALIFIED HEALTH CENTERS (FQHCS) AND DISPROPORTIONATE SHARE HOSPITALS (DSH). OUR INVOICING IS BASED ON PRESCRIPTION VOLUME AT OUR CLIENT SITES, AND IS THUS A REFLECTION OF OUR LEVEL OF ACTIVITY. IN 2018-2019 WE INVOICED APPROXIMATELY $225,548

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $1,084

Program Service Revenue $225,549

Investment Income $0

Other Revenue $0

TOTAL REVENUE $226,633

Expense Breakdown

Grants Paid $0

Salaries & Benefits $181,272

Fundraising Expenses $0

Program Expenses $465,919

Other Expenses $535,949

TOTAL EXPENSES $717,221

Year-over-Year Comparison

	2018	2017	Change
Revenue	$226,633	$1,299,953	-0.8%
Expenses	$717,221	$1,054,025	-0.3%
Net Income	$-490,588	$245,928	-3.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$150,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PETER GRISAFI	BOARD CHAIR	1.00	Officer Director	$0	$0	$0
MAURICE REID	BOARD MEMBER	1.00	Director	$0	$0	$0
STUART FELDMAN	BOARD MEMBER	1.00	Director	$0	$0	$0
JASON HARDAWAY	BOARD MEMBER	1.00	Director	$0	$0	$0
SARAH SHEFFIELD	EXECUTIVE DIRECTOR	35.00	Officer	$125,000	$25,000	$150,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2019	$226,633	$717,221	$222,316	$-490,588